Meghan A. Rego, Ph.D. - Publications

Affiliations: 
2012 Cell & Molecular Biology University of Rhode Island, Providence, RI, United States 
Area:
Cell Biology, Biogeochemistry, Genetics, Oncology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Yang JH, Hayano M, Griffin PT, Amorim JA, Bonkowski MS, Apostolides JK, Salfati EL, Blanchette M, Munding EM, Bhakta M, Chew YC, Guo W, Yang X, Maybury-Lewis S, Tian X, ... ... Rego MA, et al. Loss of epigenetic information as a cause of mammalian aging. Cell. PMID 36638792 DOI: 10.1016/j.cell.2022.12.027  0.311
2020 Fan M, Guerin K, Rego M, Bourges D, Ersing I, Haery L, Harten DeMaio K, Sanders E, Tasissa M, Kostman M, Tillgren M, Makana Hanley L, Mueller I, Mitsopoulos A. A novel next generation sequencing and analysis platform to assess the identity of rAAV preparations from rAAV DNA extracts. Human Gene Therapy. PMID 32159396 DOI: 10.1089/Hum.2019.277  0.302
2017 Vierra DA, Garzon JL, Rego MA, Adroved MM, Mauro M, Howlett NG. Modulation of the Fanconi anemia pathway via chemically induced changes in chromatin structure. Oncotarget. 8: 76443-76457. PMID 29100324 DOI: 10.18632/Oncotarget.19470  0.724
2017 Vierra DA, Garzon JL, Rego MA, Adroved MM, Mauro M, Howlett NG. Modulation of the Fanconi anemia pathway via chemically induced changes in chromatin structure. Oncotarget. PMID 28778076 DOI: 10.18632/oncotarget.19470  0.724
2013 Boisvert RA, Rego MA, Azzinaro PA, Mauro M, Howlett NG. Coordinate nuclear targeting of the FANCD2 and FANCI proteins via a FANCD2 nuclear localization signal. Plos One. 8: e81387. PMID 24278431 DOI: 10.1371/Journal.Pone.0081387  0.713
2012 Rego MA, Kolling FW, Vuono EA, Mauro M, Howlett NG. Regulation of the Fanconi anemia pathway by a CUE ubiquitin-binding domain in the FANCD2 protein. Blood. 120: 2109-17. PMID 22855611 DOI: 10.1182/Blood-2012-02-410472  0.708
2012 Mauro M, Rego MA, Boisvert RA, Esashi F, Cavallo F, Jasin M, Howlett NG. p21 promotes error-free replication-coupled DNA double-strand break repair. Nucleic Acids Research. 40: 8348-60. PMID 22735704 DOI: 10.1093/Nar/Gks612  0.723
2012 Rego MA, Harney JA, Mauro M, Shen M, Howlett NG. Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor. Oncogene. 31: 366-75. PMID 21685936 DOI: 10.1038/Onc.2011.237  0.759
2010 Rego MA, Mauro M, Harney JA, Shen M, Kolling FW, Howlett NG. Abstract LB-102: The p21Cip1/Waf1cyclin-dependent kinase inhibitor is required for the activation of the FA-BRCA pathway Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-102  0.716
2009 Howlett NG, Harney JA, Rego MA, Kolling FW, Glover TW. Functional interaction between the Fanconi Anemia D2 protein and proliferating cell nuclear antigen (PCNA) via a conserved putative PCNA interaction motif. The Journal of Biological Chemistry. 284: 28935-42. PMID 19704162 DOI: 10.1074/Jbc.M109.016352  0.733
2009 Rego MA, Kolling FW, Howlett NG. The Fanconi anemia protein interaction network: casting a wide net. Mutation Research. 668: 27-41. PMID 19101576 DOI: 10.1016/J.Mrfmmm.2008.11.018  0.719
Show low-probability matches.